Avanafil

阿伐那非

Report date: 2026/03/04 20:01:44
NME

Base Information

Drug NameAvanafil
Drug Alias Name阿伐那菲avanafilo阿瓦那非avanafilumStendra +[11] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphodiesterase 5A inhibitors
TargetsPhosphodiesterase 5A
Therapy Area/IndicationsErectile Dysfunction
Global Approved IndicationsErectile Dysfunction
Approved Indications in ChinaErectile Dysfunction
Original Approved Country/TerritorySouth Korea
Original Approved Date2011/01/01
Country/TerritoryUnited StatesRussian FederationSouth Korea +[5] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesMitsubishi Tanabe PharmaVivus LLC
China Registration ClassN/A

Develop Information

Active CompaniesHisco Pharmaceutical (Meishan) Co LtdVivus LLCVivus Inc +[4] 
Inactive CompaniesJw Pharmaceutical CorpSanofiLiaoning Haisco Pharmaceutical Co Ltd +[8] 
Active IndicationsErectile Dysfunction
Inactive IndicationsN/A

Other Information

ATC CodeG04BE10
Related LinksWikipediaDrugBankKEGG